| Literature DB >> 33424804 |
Chong Wang1,2, Jiqian Xu3, Shaoyuan Wang4, Shangwen Pan3, Jiancheng Zhang3, Yang Han2,5,6, Muhan Huang2,5, Di Wu2,5, Qingyu Yang6, Xiaobo Yang3, Yang Yang4, Ting Shu5,6, Xiaojing Zou3, Ruiting Li3, Yufeng Luo4, Runqing Yao4, Yaxin Wang3, Yang Qiu2,5, Yu Wang7, Ding-Yu Zhang6, Qun Yao6, Yongpan Yan4, Xi Zhou2,5,6, You Shang3,6,8.
Abstract
SARS-coronavirus-2-induced immune dysregulation and inflammatory responses are involved in the pathogenesis of coronavirus disease-2019 (COVID-19). However, very little is known about immune cell and cytokine alterations in specific organs of COVID-19 patients. Here, we evaluated immune cells and cytokines in postmortem tissues, i.e., lungs, intestine, liver, kidneys, and spleen of three patients with COVID-19. Imaging mass cytometry revealed monocyte, macrophage, and dendritic cell (DC) infiltration in the lung, intestine, kidney, and liver tissues. Moreover, in patients with COVID-19, natural killer T cells infiltrated the liver, lungs, and intestine, whereas B cells infiltrated the kidneys, lungs, and intestine. CD11b+ macrophages and CD11c+ DCs also infiltrated the lungs and intestine, a phenomenon that was accompanied by overproduction of the immunosuppressive cytokine interleukin (IL)-10. However, CD11b+ macrophages and CD11c+ DCs in the lungs or intestine of COVID-19 patients did not express human leukocyte antigen DR isotype. In contrast, tumor necrosis factor (TNF)-α expression was higher in the lungs, intestine, liver, and kidneys, but not in the spleen, of all COVID-19 patients (compared to levels in controls). Collectively, these findings suggested that IL-10 and TNF-α as immunosuppressive and pro-inflammatory agents, respectively,-might be prognostic and could serve as therapeutic targets for COVID-19.Entities:
Keywords: COVID-19; imaging mass cytometry (IMC); immune dysregulation; inflammatory response; organ specific response
Year: 2020 PMID: 33424804 PMCID: PMC7785801 DOI: 10.3389/fmicb.2020.600989
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640